Search
for
Sort by
Research 211–240 of 1000+
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Current aspects of polycystic ovary syndrome: A literature review
- Infertility: Evaluation and Initial Management
- Serum 1, 25-dihydroxy vitamin D- vitamin D3- among obese Egyptian women with polycystic ovary syndrome
- Synergistic Potential of Ecklonia cava and Oral Contraceptives inManaging Polycystic Ovary Syndrome: Clinical and BiochemicalEvaluation
- Holistic approaches to PCOS: Diet, Exercise and Mental well-being.
- Polycystic Ovary Syndrome: Current Insights Into Etiology, Symptoms, And Treatment Options
- Review on Diagnostic and Managerial Consequences of PCOS Among Females
- Polycystic Ovaries: A Cross Sectional Study on Unmarried Girls in KSA
- Das polyzystische Ovarsyndrom: Aktuelle Evidenz und praktische Empfehlungen
- Management of teenagers with polycystic ovarian syndrome
- Inositol versus Metformin administration in polycystic ovary syndrome patients
- Alopecia and Thyroid Disease
- Pharmakokinetik und Biokonversion von Dehydroepiandrosteron nach Dexamethason-Vorbehandlung bei Frauen mit dem Syndrom der polyzystischen Ovarien
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Rotterdam criteria–based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study
- Androgen excess is the key element in polycystic ovary syndrome
- Activation of nuclear factor κB in response to cream ingestion is related to ovarian androgen hypersecretion in polycystic ovary syndrome
- Polyzystisches Ovar-Syndrom (PCOS)
- Prevalence of androgenic alopecia (AGA) in patients with polycystic ovarian syndrome (PCOS) and characterization of associated clinical and biochemical features
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline